45 results match your criteria: "Calgary Laboratory Services and University of Calgary[Affiliation]"
Am J Surg Pathol
July 2016
*Calgary Laboratory Services and University of Calgary, Calgary, AB, Canada §§McGill University, Montreal, QC, Canada †Charles University, Pilsen, Czech Republic ‡Institute of Pathology, Friedrich-Alexander-University, Erlangen-Nürnberg, Germany ∥University Clinic Bonn, Germany §Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH ‡‡University of Michigan, Ann Arbor, MI ∥∥University of South Carolina School of Medicine, Columbia, SC ¶University of Florence, Florence, Italy #Pitié-Salpêtrière Hospital, Paris, France **Hopital Cochin, APHP, Université Paris Descartes, Paris, France ††Barts Cancer Institute, Queen Mary University of London, London, United Kingdom ¶¶Sullivan Nicolaides Pathology, Gold Coast, Qld, Australia ***Mater Hospital, South Brisbane, Qld, Australia ##Douglass Hanly Moir Pathology, North Ryde, NSW, Australia †††Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, Royal North Shore Hospital, University of Sydney, Sydney, NSW, Australia.
Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cell carcinomas (RCC) are difficult to diagnose prospectively. We used immunohistochemistry (IHC) to identify fumarate hydratase (FH)-deficient tumors (defined as FH negative, 2-succinocysteine [2SC] positive) in cases diagnosed as "unclassified RCC, high grade or with papillary pattern," or "papillary RCC type 2," from multiple institutions. A total of 124 tumors (from 118 patients) were evaluated by IHC for FH and 2SC.
View Article and Find Full Text PDFMod Pathol
March 2016
Department of Laboratory Medicine and Pathology, Royal Alexandra Hospital and University of Alberta, Edmonton, AB, Canada.
Dedifferentiated endometrial carcinoma is an aggressive type of endometrial cancer that contains a mix of low-grade endometrioid and undifferentiated carcinoma components. We performed targeted sequencing of eight dedifferentiated carcinomas and identified somatic frameshift/nonsense mutations in SMARCA4, a core ATPase of the switch/sucrose non-fermenting (SWI/SNF) complex, in the undifferentiated components of four tumors. Immunohistochemical analysis confirmed the loss of SMARCA4 in the undifferentiated component of these four SMARCA4-mutated cases, whereas the corresponding low-grade endometrioid component showed retained SMARCA4 expression.
View Article and Find Full Text PDFAm J Surg Pathol
February 2016
Department of Laboratory Medicine and Pathology, Royal Alexandra Hospital and University of Alberta, Edmonton, Alberta, Canada.
Mixed endometrial carcinoma refers to a tumor that comprises 2 or more distinct histotypes. We studied 18 mixed-type endometrial carcinomas-11 mixed serous and low-grade endometrioid carcinomas (SC/EC), 5 mixed clear cell and low-grade ECs (CCC/EC), and 2 mixed CCC and SCs (CCC/SC), using targeted next-generation sequencing and immunohistochemistry to compare the molecular profiles of the different histotypes present in each case. In 16 of 18 cases there was molecular evidence that both components shared a clonal origin.
View Article and Find Full Text PDFAm J Surg Pathol
January 2016
*Calgary Laboratory Services and University of Calgary, Calgary, AB, Canada †Department of Pathology, Charles University, Pilsen, Czech Republic ‡Cruces University Hospital, BioCruces Institute, University of the Basque Country (UPV/EHU), Barakaldo, Bizkaia, Spain §Nephropath, Little Rock, AR ‡‡Medical College Wisconsin, Milwaukee, WI §§El Camino Hospital, Mountain View ∥∥Stanford University Hospital, Stanford, CA ¶¶New York University Medical Center, New York, NY ***Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH ∥Carregi Hospital, Florence, Italy ¶Pitié-Salpêtrière Hospital #Hopital Cochin, Paris, France **Barts Cancer Institute, Queen Mary University of London, London, United Kingdom ††University Hospital Dubrava, Zagreb, Croatia ##Royal North Shore Hospital, University of Sydney, Sydney, NSW, Australia.
A unique renal neoplasm characterized by eosinophilic cytoplasm and solid and cystic growth was recently reported in patients with tuberous sclerosis complex (TSC). We searched multiple institutional archives and consult files in an attempt to identify a sporadic counterpart. We identified 16 morphologically identical cases, all in women, without clinical features of TSC.
View Article and Find Full Text PDFAppl Immunohistochem Mol Morphol
February 2016
*Department of Pathology and Cytology, Clinical Center of the University of Sarajevo, Sarajevo, Bosnia and Herzegovina †Ljudevit Jurak Department of Pathology, Sestre milosrdnice Clinical Hospital Center ††Department of Pathology, University Hospital Dubrava, Zagreb, Croatia Departments of ‡Pathology ∥Urology, Charles University, Faculty of Medicine and University Hospital Plzeň ‡‡Biomedical Centre, Faculty of Medicine in Plzen, Charles University in Prague, Plzen, Czech Republic §Department of Pathology and Laboratory Medicine, Calgary Laboratory Services and University of Calgary, Calgary, AB, Canada ¶Department of Pathology, East University Riga, Riga, Latvia #Department of Pathology, Institute Nacional de Cancerologia **Department of Pathology, Centro Medico, Mexico City, Mexico.
Renal oncocytoma (RO) may present with a tubulocystic growth in 3% to 7% of cases, and in such cases its morphology may significantly overlap with tubulocystic renal cell carcinoma (TCRCC). We compared the morphologic and immunohistochemical characteristics of these tumors, aiming to clarify the differential diagnostic criteria, which facilitate the discrimination of RO from TCRCC. Twenty-four cystic ROs and 15 TCRCCs were selected and analyzed for: architectural growth patterns, stromal features, cytomorphology, ISUP nucleolar grade, necrosis, and mitotic activity.
View Article and Find Full Text PDFInt J Gynecol Pathol
November 2015
Department of Pathology and Laboratory Medicine, Vancouver General Hospital and University of British Columbia, Vancouver, Canada (L.N.H., S.Z., D.H., C.B.G.) Department of Histopathology, King Edward Memorial Hospital, Perth, Western Australia, Australia (A.S.) Department of Pathology and Laboratory Medicine, Calgary Laboratory Services and University of Calgary, Calgary, Canada (M.K.) Department of Laboratory Medicine and Pathology, Royal Alexandra Hospital and University of Alberta, Edmonton, Canada (C.H.L.) Department of Gynecology and Obstetrics, University of British Columbia, Vancouver, BC, Canada (J.N.M., D.H.) Department of Pathology, British Columbia Cancer Agency, Vancouver, BC, Canada (D.H., T.T., D.V.N.) Department of Cellular Pathology, Barts and the London NHS Trust, London, United Kingdom (N.S.).
Growing insights into the biological features and molecular underpinnings of ovarian cancer has prompted a shift toward histotype-specific treatments and clinical trials. As a result, the preoperative diagnosis of ovarian carcinomas based on small tissue sampling is rapidly gaining importance. The data on the accuracy of ovarian carcinoma histotype-specific diagnosis based on small tissue samples, however, remains very limited in the literature.
View Article and Find Full Text PDFAm J Surg Pathol
October 2015
*New York University Medical Center, New York, NY †Cleveland Clinic, Cleveland, OH ‡Indiana University, Indianapolis, IN ∥The University of Michigan, Ann Arbor, MI ¶Division of Urologic Pathology, Miraca Life Sciences Research Institute, Miraca Life Sciences, Irving ††Houston Methodist Hospital, Houston, TX #Emory University School of Medicine, Atlanta, GA **University of Chicago ∥∥Northwestern Medical Center, Chicago, IL §Karolinska Institutet, Stockholm, Sweden ‡‡Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan §§Calgary Laboratory Services and University of Calgary, Calgary, AB, Canada.
Accurate recognition of Gleason pattern (GP) 4 prostate carcinoma (PCa) on needle biopsy is critical for patient management and prognostication. "Poorly formed glands" are the most common GP4 subpattern. We studied the diagnostic reproducibility and the quantitative threshold of grading GP4 "poorly formed glands" and the criteria to distinguish them from tangentially sectioned GP3 glands.
View Article and Find Full Text PDFHistopathology
August 2015
Department of Pathology and Laboratory Medicine, Calgary Laboratory Services and University of Calgary, Calgary, AB, Canada.
Aims: To present a series of urinary bladder xanthomas and characterize their clinical features and associated pathology.
Methods And Results: We retrieved the clinicopathological data of bladder xanthomas, with and without associated urothelial neoplasms. We identified six isolated bladder xanthomas and 11 arising within or adjacent to urothelial neoplasms.
Am J Surg Pathol
March 2015
*Department of Pathology, Vancouver General Hospital and University of British Columbia, Vancouver †Department of Pathology, Royal Jubilee Hospital, Victoria, BC ‡Department of Pathology, Calgary Laboratory Services and University of Calgary, AB §Department of Pathology, Royal Alexandra Hospital and University of Alberta, Edmonton AB ∥Department of Cellular Pathology, Barts Health NHS Trust, London ¶Department of Histopathology, St James's Hospital, Leeds #Department of Pathology, Belfast Health and Social Care Trust, Belfast, United Kingdom.
Most nonuterine high-grade serous carcinomas (HGSCs) in women with hereditary breast and ovarian cancer syndrome, due to germline BRCA1/2 mutation, arise in the fimbria of the fallopian tube. However, the site of origin of sporadic HGSC, which is usually widely disseminated at presentation, is not well established. We sought to characterize cases of HGSC discovered incidentally in patients not known to be at high risk, in order to determine the site distribution and possible origin of sporadic HGSC.
View Article and Find Full Text PDFAm J Surg Pathol
December 2014
*Department of Anatomical Pathology †Cancer Diagnosis and Pathology Research Group §§Cancer Genetics, Kolling Institute of Medical Research, Royal North Shore Hospital ‡University of Sydney, Sydney ††Histopath Pathology ¶¶Douglass Hanly Moir Pathology, North Ryde ‡‡Department of Anatomical Pathology, St Vincents Hospital, Darlinghurst §§§Department of Anatomical Pathology, South Western Area Pathology Service, Liverpool, NSW ∥∥Pathology Queensland, Gold Coast University Hospital, Qld ****Department of Anatomical Pathology, Royal Children's Hospital, Parkville, Vic., Australia §Department of Pathology, Medical Faculty and Charles University, Pilsen, Czech Republic ∥Department of Pathology, Josephine Nefkens Institute, Erasmus Medical Centre, Rotterdam ##Department of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands ¶Department of Pathology, Singapore General Hospital, Singapore, Singapore #Institute of Pathology, Friedrich-Alexander-University, Erlangen, Germany **Department of Pathology, Oslo University Hospital ***Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway †††Robert J Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH ¶¶¶Department of Pathology, Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI ††††Laboratory of Surgical Pathology, National Cancer Institute, Bethesda, MD ‡‡‡Department of Pathology and Laboratory Medicine, Calgary Laboratory Services and University of Calgary, Calgary, AB, Canada ∥∥∥Department of Pathology, Hopital Cochin Université Paris Descartes, Paris, France ###Department of Molecular Pathology, University of Dundee, Ninewells Hospital, Dundee, UK.
Succinate dehydrogenase (SDH)-deficient renal carcinoma has been accepted as a provisional entity in the 2013 International Society of Urological Pathology Vancouver Classification. To further define its morphologic and clinical features, we studied a multi-institutional cohort of 36 SDH-deficient renal carcinomas from 27 patients, including 21 previously unreported cases. We estimate that 0.
View Article and Find Full Text PDFHistopathology
June 2014
Department of Pathology and Laboratory Medicine, Calgary Laboratory Services and University of Calgary, Calgary, AB, Canada.
Aims: To assess the variation in ovarian carcinoma type diagnosis among gynaecological pathologists from Nordic countries, and whether a rationally designed panel of immunohistochemical markers could improve diagnostic reproducibility.
Methods And Results: Eight pathologists from four countries (Sweden, Denmark, Norway, and Finland) received an educational lecture on the diagnosis of ovarian carcinoma type. All tumour-containing slides from 54 ovarian carcinoma cases were independently reviewed by the participants, who: (i) determined type purely on the basis of histology; (ii) indicated whether they would apply immunohistochemistry in their routine practice; and (iii) determined type after reviewing the staining results.
Mod Pathol
April 2013
Department of Pathology and Laboratory Medicine, Calgary Laboratory Services and University of Calgary, Calgary, Alberta, Canada.
Clinical staging is a critical step in the management of testicular germ cell tumors. Up to one-third of nonseminomatous germ cell tumors of the testis present with metastatic disease (clinical stages II and III). We investigated the predictors of metastatic disease at presentation in a cohort of 148 consecutive nonseminomatous germ cell tumors of the testis, over a 10-year period.
View Article and Find Full Text PDFDiagn Pathol
August 2011
Department of Pathology and Laboratory Medicine, Calgary Laboratory Services and University of Calgary, Rockyview General Hospital, 7007 14 st, Calgary, T2V 1P9, Alberta, Canada.
Mesothelioma of tunica vaginalis is a rare neoplasm, typically demonstrating frankly malignant morphology and aggressive behavior. Rare cases of well-differentiated papillary mesotheliomas have also been reported, which, in contrast, demonstrate indolent behavior. There are, however, cases which do not fit into the well-differentiated or diffuse malignant mesothelioma categories and can be considered mesothelioma of tunica vaginalis of "uncertain malignant potential", which is an emerging diagnostic category.
View Article and Find Full Text PDFHum Pathol
December 2011
Department of Pathology and Laboratory Medicine, Calgary Laboratory Services and University of Calgary, Calgary, T2V 1P9 Alberta, Canada.
A classification schema for grading Polyomavirus nephropathy was proposed at the 2009 Banff allograft meeting. The schema included 3 stages of Polyomavirus nephropathy: early (stage A), florid (stage B), and late sclerosing (stage C). Grading categories for histologic viral load levels were also proposed.
View Article and Find Full Text PDFHistopathology
December 2010
Department of Pathology and Laboratory Medicine, Calgary Laboratory Services and University of Calgary, Calgary, Alberta, Canada.
Aim: To evaluate problematic diagnostic features in renal oncocytoma.
Methods And Results: One hundred and nine cases of oncocytoma were reviewed and the problematic gross and microscopic features recorded. Multifocal and bilateral neoplasms were found in 12 (11%) and five (4.
Histopathology
October 2009
Department of Pathology and Laboratory Medicine, Calgary Laboratory Services and University of Calgary, Calgary, Canada.
Aims: To investigate the impact of the 2005 International Society of Urological Pathology (ISUP) Gleason grading consensus in contemporary practice.
Methods And Results: The Gleason scores (GS) were compared in two consecutive patient cohorts with matched biopsies and prostatectomies: (i) 908 patients evaluated before the ISUP consensus (July 2000-June 2004) and (ii) 423 patients evaluated after the ISUP consensus (October 2005-June 2007). All biopsies and prostatectomies were performed and scored in one institution and were sampled and processed identically.
Am J Clin Pathol
August 2009
Anatomical Pathology, Rockyview General Hospital, Department of Pathology and Laboratory Medicine, Calgary Laboratory Services and University of Calgary, 7007 - 14 Street SW, Calgary, Alberta T2V 1P9, Canada.
We evaluated the usefulness of double immunohistochemical staining for cytokeratin (CK)5/6 and alpha-methylacyl coenzyme A racemase (AMACR) applied sequentially on 1 slide by assessing 223 foci in 110 consecutive prostate specimens. Double-chromogen reaction was used to visualize the antibodies: brown for CK5/6 and red for AMACR. Staining was scored as diffuse, focal, or negative.
View Article and Find Full Text PDFArch Pathol Lab Med
August 2008
Department of Pathology and Laboratory Medicine, Anatomical Pathology, Rockyview General Hospital, Calgary Laboratory Services and University of Calgary, Calgary, Alberta, Canada.
Context: When minimal prostate cancer is detected in the initial transurethral resection of the prostate (TURP) sample, it is uncertain how extensively the remaining tissue should be sampled for accurate grading and staging.
Objective: To identify whether additional partial or complete sampling is required to accurately evaluate TURP samples with minimal cancer (stage T1a).
Design: We prospectively examined all TURP samples in our institution during 1 year.
Int J Gynecol Pathol
October 2005
Department of Pathology and Laboratory Medicine, Calgary Laboratory Services and University of Calgary, Calgary, Alberta, Canada.
We describe eight unusual uterine leiomyomas characterized by a component of cells that suggested skeletal muscle differentiation or resembled the rhabdoid cells of extrarenal rhabdoid tumors. All of the tumors were referred because of problems in differential diagnosis, particularly distinction from an epithelioid smooth muscle tumor, a smooth muscle tumor of uncertain malignant potential, or a tumor with skeletal muscle differentiation. The patients were aged 27 to 50 (mean, 38) years, and the presenting clinical features and gross appearance of the tumors were similar to those of typical uterine leiomyomas.
View Article and Find Full Text PDFInt J Gynecol Cancer
November 2000
Mercy Pathology, Mercy Hospital for Women, Melbourne, Australia;Department of Radiation Oncology, Tom Baker Cancer Center, Calgary; and Department of Laboratory Medicine, Calgary Laboratory Services and University of Calgary, Canada.
The pathology of cervical involvement in endometrial carcinoma has not been fully defined previously. We reviewed the histopathology of 66 hysterectomies of women with stage II endometrial carcinoma. Cervical spread was categorized as macroscopic or microscopic; stage IIA or IIB; direct spread, surface or lymphvascular metastasis; and size, number, and location.
View Article and Find Full Text PDF